366 related articles for article (PubMed ID: 19726691)
1. Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle.
Undurti A; Huang Y; Lupica JA; Smith JD; DiDonato JA; Hazen SL
J Biol Chem; 2009 Nov; 284(45):30825-35. PubMed ID: 19726691
[TBL] [Abstract][Full Text] [Related]
2. An abundant dysfunctional apolipoprotein A1 in human atheroma.
Huang Y; DiDonato JA; Levison BS; Schmitt D; Li L; Wu Y; Buffa J; Kim T; Gerstenecker GS; Gu X; Kadiyala CS; Wang Z; Culley MK; Hazen JE; Didonato AJ; Fu X; Berisha SZ; Peng D; Nguyen TT; Liang S; Chuang CC; Cho L; Plow EF; Fox PL; Gogonea V; Tang WH; Parks JS; Fisher EA; Smith JD; Hazen SL
Nat Med; 2014 Feb; 20(2):193-203. PubMed ID: 24464187
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex.
Huang Y; Wu Z; Riwanto M; Gao S; Levison BS; Gu X; Fu X; Wagner MA; Besler C; Gerstenecker G; Zhang R; Li XM; DiDonato AJ; Gogonea V; Tang WH; Smith JD; Plow EF; Fox PL; Shih DM; Lusis AJ; Fisher EA; DiDonato JA; Landmesser U; Hazen SL
J Clin Invest; 2013 Sep; 123(9):3815-28. PubMed ID: 23908111
[TBL] [Abstract][Full Text] [Related]
4. HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of function.
Berisha SZ; Brubaker G; Kasumov T; Hung KT; DiBello PM; Huang Y; Li L; Willard B; Pollard KA; Nagy LE; Hazen SL; Smith JD
J Lipid Res; 2015 Mar; 56(3):653-664. PubMed ID: 25561462
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.
Zheng L; Nukuna B; Brennan ML; Sun M; Goormastic M; Settle M; Schmitt D; Fu X; Thomson L; Fox PL; Ischiropoulos H; Smith JD; Kinter M; Hazen SL
J Clin Invest; 2004 Aug; 114(4):529-41. PubMed ID: 15314690
[TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase Targets Apolipoprotein A-I for Site-Specific Tyrosine Chlorination in Atherosclerotic Lesions and Generates Dysfunctional High-Density Lipoprotein.
Jin Z; Zhou L; Tian R; Lu N
Chem Res Toxicol; 2021 Jun; 34(6):1672-1680. PubMed ID: 33861588
[TBL] [Abstract][Full Text] [Related]
7. Formation of dysfunctional high-density lipoprotein by myeloperoxidase.
Nicholls SJ; Zheng L; Hazen SL
Trends Cardiovasc Med; 2005 Aug; 15(6):212-9. PubMed ID: 16182131
[TBL] [Abstract][Full Text] [Related]
8. Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport.
Marsche G; Hammer A; Oskolkova O; Kozarsky KF; Sattler W; Malle E
J Biol Chem; 2002 Aug; 277(35):32172-9. PubMed ID: 12070141
[TBL] [Abstract][Full Text] [Related]
9. Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma.
DiDonato JA; Huang Y; Aulak KS; Even-Or O; Gerstenecker G; Gogonea V; Wu Y; Fox PL; Tang WH; Plow EF; Smith JD; Fisher EA; Hazen SL
Circulation; 2013 Oct; 128(15):1644-55. PubMed ID: 23969698
[TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein.
Lu N; Xie S; Li J; Tian R; Peng YY
Clin Chim Acta; 2015 Feb; 441():163-70. PubMed ID: 25528002
[TBL] [Abstract][Full Text] [Related]
11. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I.
Shao B; Oda MN; Bergt C; Fu X; Green PS; Brot N; Oram JF; Heinecke JW
J Biol Chem; 2006 Apr; 281(14):9001-4. PubMed ID: 16497665
[TBL] [Abstract][Full Text] [Related]
12. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins.
Malle E; Marsche G; Panzenboeck U; Sattler W
Arch Biochem Biophys; 2006 Jan; 445(2):245-55. PubMed ID: 16171772
[TBL] [Abstract][Full Text] [Related]
13. Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Restores PON1 Activity.
Huang J; Yancey PG; Tao H; Borja MS; Smith LE; Kon V; Davies SS; Linton MF
Nutrients; 2020 Jun; 12(7):. PubMed ID: 32629758
[TBL] [Abstract][Full Text] [Related]
14. Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins?
Vuilleumier N; Dayer JM; von Eckardstein A; Roux-Lombard P
Swiss Med Wkly; 2013; 143():w13781. PubMed ID: 23740387
[TBL] [Abstract][Full Text] [Related]
15. Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein.
Shao B; Oda MN; Oram JF; Heinecke JW
Chem Res Toxicol; 2010 Mar; 23(3):447-54. PubMed ID: 20043647
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport.
Shao B; Bergt C; Fu X; Green P; Voss JC; Oda MN; Oram JF; Heinecke JW
J Biol Chem; 2005 Feb; 280(7):5983-93. PubMed ID: 15574409
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein.
Smith JD
J Clin Lipidol; 2010; 4(5):382-8. PubMed ID: 21076633
[TBL] [Abstract][Full Text] [Related]
18. Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis.
Zamanian-Daryoush M; Gogonea V; DiDonato AJ; Buffa JA; Choucair I; Levison BS; Hughes RA; Ellington AD; Huang Y; Li XS; DiDonato JA; Hazen SL
J Biol Chem; 2020 Apr; 295(15):4836-4848. PubMed ID: 32098873
[TBL] [Abstract][Full Text] [Related]
19. The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction.
Wu Z; Wagner MA; Zheng L; Parks JS; Shy JM; Smith JD; Gogonea V; Hazen SL
Nat Struct Mol Biol; 2007 Sep; 14(9):861-8. PubMed ID: 17676061
[TBL] [Abstract][Full Text] [Related]
20. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
